VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹18 Cr | ₹60 Cr | ₹58 Cr | ₹46 Cr | ₹58 Cr |
What is the latest Total Non-Current Liabilities ratio of VENUS REMEDIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹58 Cr |
| Mar2022 | ₹46 Cr |
| Mar2021 | ₹58 Cr |
How is Total Non-Current Liabilities of VENUS REMEDIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | -69.12 | |
| Mar2024 | ₹60 Cr | 2.89 | |
| Mar2023 | ₹58 Cr | 26.60 | |
| Mar2022 | ₹46 Cr | -20.94 | |
| Mar2021 | ₹58 Cr | - | |
Compare Total Non-Current Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹917.3 Cr | -9.7% | -12.8% | 117.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -9.7% |
-12.8% |
117.5% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses